ECM
NAGE

ExodusPoint Capital Management’s Niagen Bioscience NAGE Stock Holding History

ExodusPoint Capital Management’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$97.6K Buy
+22,122
New +$119K ﹤0.01% 1437
2024
Q4 		– Sell
-39,900
Closed -$146K – 2205
2024
Q3 		$146K Buy
+39,900
New +$126K ﹤0.01% 1486
2024
Q2 		– Sell
-20,930
Closed -$73K – 2107
2024
Q1 		$73K Buy
+20,930
New +$38.7K ﹤0.01% 1426
2021
Q3 		– Sell
-12,792
Closed -$126K – 2754
2021
Q2 		$126K Sell
12,792
-19,977
-61% -$174K ﹤0.01% 2100
2021
Q1 		$306K Buy
+32,769
New +$260K 0.01% 1657

Other funds holding NAGE

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.8B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return